top of page

STELARA CONCENTRATE FOR SOLUTION FOR INFUSION 130MG/26ML

Product details

Registration number: SIN15438P

Classification: Prescription Only

Active ingredients: ustekinumab

Strength: 130mg/vial

Dosage form: INFUSION, SOLUTION CONCENTRATE

Route: INTRAVENOUS

Registrant: JOHNSON & JOHNSON INTERNATIONAL (SINGAPORE) PTE LTD

ATC code: L04AC05

HSA approval date: 28 February 2018

Manufacturer(s): Cilag AG

Manufacturing country/countries: SWITZERLAND

What are the HSA registration number and classification for STELARA CONCENTRATE FOR SOLUTION FOR INFUSION 130MG/26ML?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN15438P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for STELARA CONCENTRATE FOR SOLUTION FOR INFUSION 130MG/26ML?

According to the HSA dataset updated 7 August 2026:

Active ingredients: ustekinumab

Strength: 130mg/vial

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for STELARA CONCENTRATE FOR SOLUTION FOR INFUSION 130MG/26ML?

According to the HSA dataset updated 7 August 2026:

Dosage form: INFUSION, SOLUTION CONCENTRATE

Route: INTRAVENOUS

Source for this answer

Who is the recorded registrant for STELARA CONCENTRATE FOR SOLUTION FOR INFUSION 130MG/26ML?

According to the HSA dataset updated 7 August 2026:

Registrant: JOHNSON & JOHNSON INTERNATIONAL (SINGAPORE) PTE LTD

Source for this answer

Which manufacturers and countries are listed for STELARA CONCENTRATE FOR SOLUTION FOR INFUSION 130MG/26ML?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): Cilag AG

Manufacturing country/countries: SWITZERLAND

Source for this answer

Where can I look up STELARA CONCENTRATE FOR SOLUTION FOR INFUSION 130MG/26ML in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN15438P or the exact product name STELARA CONCENTRATE FOR SOLUTION FOR INFUSION 130MG/26ML. The general register link does not preselect this product.

Source for this answer

What are the source dates for this STELARA CONCENTRATE FOR SOLUTION FOR INFUSION 130MG/26ML record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this STELARA CONCENTRATE FOR SOLUTION FOR INFUSION 130MG/26ML record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN15438P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page